Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis

NCT00608322 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

Sepsis

Interventions

DRUG: Inhaled nitric oxide
OTHER: Sham inhaled nitric oxide

Sponsor

National Institute of General Medical Sciences (NIGMS)